ADVANCED NSCLC
Clinical trials for ADVANCED NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could your own tumor cells beat lung cancer? new trial aims to find out
Disease control Recruiting nowThis study tests a treatment that uses your own immune cells taken from your tumor, grown in a lab, and given back to you to fight advanced non-small cell lung cancer. The goal is to see if these cells can shrink tumors and if the treatment is safe. Participants must be 18-72 and…
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for advanced lung cancer patients: experimental combo targets tumors from two angles
Disease control Recruiting nowThis study tests a new drug called JS207, which targets two proteins (PD-1 and VEGF) that help tumors grow. It is given alone or with another drug (JS004 or docetaxel) to 66 adults with advanced non-small cell lung cancer that got worse after standard chemotherapy and immunothera…
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC